Copyright
©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Mar 7, 2008; 14(9): 1394-1398
Published online Mar 7, 2008. doi: 10.3748/wjg.14.1394
Published online Mar 7, 2008. doi: 10.3748/wjg.14.1394
Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma
Hong Seok Jang, Byung Ock Choi, Department of Radiation Oncology, The Catholic University of Korea, School of Medicine, Seoul, Korea
Ki Mun Kang, Gyu Young Chai, Department of Radiation Oncology, Gyeongsang National University, Postgraduate School of Medicine, Gyeongsang Institute of Health Sciences, Jinju 660-702, Korea
Soon Chan Hong, Woo Song Ha, Department of Surgery, Gyeongsang National University, Postgraduate School of Medicine, Jinju 660-702, Korea
Randy L Jirtle, Department of Radiation Oncology, Duke University Medical Center, Durham, NC, United States
Correspondence to: Ki Mun Kang, MD, PhD, Department of Radiation Oncology, Gyeongsang National University, School of Medicine, 90 Chilamdong, Jinju 660-702, Korea. jsk92@gnu.ac.kr
Telephone: +82-55-7509202
Fax: +82-55-7509095
Received: October 14, 2007
Revised: November 30, 2007
Published online: March 7, 2008
Revised: November 30, 2007
Published online: March 7, 2008
Core Tip